- Home
- GDTC vs CLIR Comparison
GDTC vs CLIR Comparison
Compare GDTC & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- CLIR
- Stock Information
- Founded
- GDTC 2018
- CLIR 2008
- Country
- GDTC Singapore
- CLIR United States
- Employees
- GDTC N/A
- CLIR N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- GDTC Health Care
- CLIR Industrials
- Exchange
- GDTC Nasdaq
- CLIR Nasdaq
- Market Cap
- GDTC 21.5M
- CLIR 31.2M
- IPO Year
- GDTC 2023
- CLIR 2012
- Fundamental
- Price
- GDTC $1.86
- CLIR $0.59
- Analyst Decision
- GDTC Buy
- CLIR Strong Buy
- Analyst Count
- GDTC 1
- CLIR 1
- Target Price
- GDTC $5.00
- CLIR $2.00
- AVG Volume (30 Days)
- GDTC 18.1K
- CLIR 87.0K
- Earning Date
- GDTC 01-01-0001
- CLIR 08-13-2025
- Dividend Yield
- GDTC N/A
- CLIR N/A
- EPS Growth
- GDTC N/A
- CLIR N/A
- EPS
- GDTC N/A
- CLIR N/A
- Revenue
- GDTC $368,838.00
- CLIR $2,895,000.00
- Revenue This Year
- GDTC $5.37
- CLIR $27.61
- Revenue Next Year
- GDTC N/A
- CLIR $116.19
- P/E Ratio
- GDTC N/A
- CLIR N/A
- Revenue Growth
- GDTC N/A
- CLIR 10.88
- 52 Week Low
- GDTC $1.20
- CLIR $0.46
- 52 Week High
- GDTC $4.05
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- GDTC 35.89
- CLIR 56.44
- Support Level
- GDTC $1.85
- CLIR $0.50
- Resistance Level
- GDTC $1.95
- CLIR $0.63
- Average True Range (ATR)
- GDTC 0.10
- CLIR 0.04
- MACD
- GDTC -0.02
- CLIR 0.01
- Stochastic Oscillator
- GDTC 23.53
- CLIR 74.94
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.